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Abstract
 
Committed T helper type 1 (Th1) and Th2 effector cells, resulting from chronic antigenic
stimulation in interleukin (IL)-12 and IL-4, are implicated in the pathology of autoimmune
and allergic diseases. Committed Th1 cells cannot be induced to change their cytokine profiles
in response to antigenic stimulation and Th2 cytokine–inducing conditions. Here, we report
that ectopic expression of GATA-3 induced Th2-specific cytokine expression not only in de-
veloping Th1 cells but also in otherwise irreversibly committed Th1 cells and a Th1 clone,
HDK1. Moreover, cAMP, an inhibitor of cytokine production by Th1 cells, markedly aug-
mented Th2 cytokine production in GATA-3–expressing Th1 cells. Ectopic expression of
GATA-3 in developing Th1 cells, but not in Th1 clone HDK1, induced endogenous GATA-3,
suggesting an autoregulatory mechanism for maintenance of GATA-3 expression in Th2 cells.
Structure–function analyses of GATA-3 revealed that the NH
 
2
 
-terminal transactivation do-
main and the COOH-terminal zinc finger domain of GATA-3 were critical, whereas the
NH
 
2
 
-terminal zinc finger domain was dispensable for the induction of IL-4. Both zinc fingers,
however, were required for IL-5 induction. A Th2-specific DNaseI-hypersensitive site of the
IL-4 locus was detected in GATA-3–expressing Th1 cells. Thus, GATA-3 can change the
phenotype of committed Th1 cells, previously considered to be irreversible.
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Introduction
 
Th1 and Th2 cells produce distinct sets of cytokines and
 
dictate distinct immune responses. Th1 cells produce IFN-
 
g
 
,
 
TNF-
 
b
 
, and IL-2 and promote effective immune responses
against intracellular pathogens, although they have also
been implicated in autoimmune pathologies. Th2 cells pro-
duce IL-4, IL-5, IL-6, and IL-13 and eradicate extracellular
parasites but also mediate allergic and atopic manifestations
(1–5). Development of an appropriate Th response to a
pathogen is critical for the outcome of a protective im-
mune response (3–5). Cytokines present at the initiation of
CD4 T cell responses predominantly determine the devel-
opment of a particular Th subtype. IL-12 and IL-4 direct
Ag-stimulated naive CD4 T cells toward Th1 and Th2 de-
velopment, respectively (4–6).
 
Development of committed Th1 and Th2 phenotypes
displaying an exclusive cytokine pattern is achieved largely
after repeated antigenic stimulation under appropriate con-
ditions. Although cytokine signals may modulate the phe-
notypes of Th1 and Th2 populations at an early stage of de-
velopment, these subsets become irreversible after repeated
stimulation (7–9). However, as studies on the reversibility
of Th phenotypes have been conducted at the population
rather than the single-cell level, it is not clear whether the
observed phenotype switch is a result of a true phenotype
conversion of Th cells. Rather, evidence indicates that the
development of uncommitted precursors coexisting in the
polarized Th population contributed to any observed phe-
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notypic change (10). So far there has been no indication
that committed Th1 or Th2 cells can be converted to ex-
press cytokines of the other subset. The selective loss of cy-
tokine signaling between Th1 and Th2 cells was postulated
as a molecular basis for this irreversibility. Evidence indi-
cates that IL-4–induced Th2 development rapidly blocks
IL-12 signaling by extinguishing IL-12R
 
b
 
2 expression (11,
12). Conversely, a selective defect in IL-4 signaling in com-
mitted Th1 cells has also been reported (13, 14).
Recent efforts have defined several transcription factors,
in addition to cytokines, which are differentially expressed
by Th1 and Th2 cells: GATA-3, c-Maf in Th2 cells (15,
16), and ERM in Th1 cells (17). These subtype-specific
transcription factors may be involved in Th1- and Th2-spe-
cific cytokine expression by directly activating cytokine
gene promoters (15, 17–20). For example, the Th2-specific
transcription factor GATA-3, in cooperation with a fac-
tor(s) induced upon TCR signaling, governs Th2-specific
expression of the IL-5 gene by directly interacting with a
critical regulatory element of its promoter (19, 20). How-
ever, whether GATA-3 directly activates the IL-4 promoter
remains unclear (16, 21, 22). The mechanism for Th2-spe-
cific expression of GATA-3 remains largely unknown. One
report indicated that signaling through IL-4 induces high-
level expression of GATA-3, which in turn blocks IL-12
signaling by inhibiting expression of IL-12R
 
b
 
2 (23). Con-
versely, signaling through IL-12 resulted in extinction of
GATA-3 transcripts (23). In the hematopoietic system,
GATA-3 is predominantly expressed by T cells (24, 25) and
is critical for thymocyte development (26) and for the regu-
lation of effector T cells (16). Despite the critical biological
roles of GATA-3, the molecular mechanisms by which it
exerts its functions remain elusive. GATA-3 appears to play
a dominant role in regulating Th1 and Th2 development, as
ectopic expression of GATA-3 in developing Th1 cells
gave rise to Th2 cytokine induction (16, 23, 27) as well as
to Th1 cytokine inhibition (23, 27). However, it was spec-
ulated that GATA-3 may act early during a temporarily re-
stricted window of development (23). It is possible that a
difference in additional signaling pathways between Th1
and Th2 cells may also dictate distinct cytokine expression
patterns. For example, the TCR-mediated mitogen-acti-
vated protein kinase pathways and calcium influx appear to
be selectively impaired in Th2 but not in Th1 cells (28, 29).
There is also an indication that cAMP levels are higher in
Th2 cells than in Th1 cells (30) and that molecules that ele-
vate intracellular cAMP inhibit cytokine production by Th1
cells and conversely augment cytokine production by Th2
cells (31, 32). However, the molecular mechanism by which
cAMP differentially affects cytokine production by Th1 and
Th2 cells is still not well understood.
In this study, we demonstrate that ectopic expression of
GATA-3 in committed Th1 cells induces Th2 cytokine
expression, which was enhanced by cAMP. Moreover, a
Th2-specific DNaseI-hypersensitive (HS)
 
1
 
 site of the IL-4
 
locus is demonstrated in committed Th1 cells that express
GATA-3.
 
Materials and Methods
 
Cytokines, Antibodies for Cytokines, and Oligo Peptide.
 
Recombi-
nant mouse IL-2, IL-4 (DNAX), and IL-12 (PharMingen) and rat
anti–mouse IL-4 (11B11; reference 33) and anti–IL-12
(C17.8.20; reference 34) antibodies (gifts of Drs. W.E. Paul [Na-
tional Institutes of Health, Bethesda, MD] and G. Trinchieri
[Schering-Plough Corp., Dardilly, France], respectively) were
used. The antigenic peptide from chicken OVA
 
323–339 
 
was pre-
pared as described previously (35).
 
Cell Culture and In Vitro Development of Transgenic CD4
 
1
 
 T
Cells.
 
T cells were maintained in RPMI 1640 medium supple-
mented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin,
100 
 
m
 
g/ml streptomycin, 50 
 
m
 
M 2-ME, 10 mM Hepes buffer, 1
mM sodium pyruvate (cRPMI), and appropriate cytokines. Prep-
aration of splenocytes from DO11.10 
 
a/b
 
 TCR–transgenic mice
(35) and culture conditions for polarized Th1 and Th2 popula-
tions were as previously described (9). HDK1, a KLH-specific
Th1 clone derived from BALB/c mice, was maintained as previ-
ously described (36).
 
Retroviral Vectors and Retroviral Infection.
 
The Moloney mu-
rine leukemia virus–based bicistronic retroviral vectors (37)
pMXI-EGFP (enhanced green fluorescent protein) and pMXI-
GATA-3-EGFP and the Phoenix-Eco packaging cell line (38)
were described previously (27). The retroviral vector encoding
the GATA-3 mutant, dND, containing a 140–amino acid (aa)
deletion (aa 29–168), was made by excising the SmaI fragment,
KRR (GATA-3 mutant with three substitutions between two
zinc fingers) containing a 3-aa substitution of KRR
 
®
 
AAA (aa
304–306); dNF (GATA-3 mutant lacking a portion of the NH
 
2
 
-
terminal zinc finger domain), containing an 8-aa deletion (aa
280–287), and dCF (GATA-3 mutant lacking the entire COOH-
terminal zinc finger domain), containing a 17-aa deletion (aa
309–325), were generated by PCR mutagenesis. The integrity of
each mutation was confirmed by DNA sequencing. Retroviral
transduction of T cells was carried out as previously described
(27, 39), with some modifications.
 
Measurement of Cytokines by Immunoassay and Flow Cytometry.
 
T cells (5 
 
3 
 
10
 
4
 
 per 200 
 
m
 
l per well) were stimulated with
either PMA (50 ng/ml; Calbiochem)/ionomycin (1 
 
m
 
M;
Calbiochem) or PMA/ionomycin/cAMP (1 mM; N
 
6
 
,O
 
2
 
-
dibutyryl cAMP; Sigma-Aldrich). The level of cytokines in
the supernatants was determined by immunoassay and flow
cytometry as previously described (9).
 
RNA Preparation and RNase Protection Assay.
 
For the GATA-3
and c-
 
maf
 
 riboprobes, pGEMGATA-3(BH), containing a Hind-
III–BglII fragment from murine GATA-3 cDNA (25), and pSKc-
 
maf
 
 (40), containing a full-length coding sequence of c-
 
maf
 
cDNA, were used by linearizing with AflIII and BglII, respec-
tively. RNA extraction and RNase protection assays were per-
formed as described previously (39).
 
Western Blot Analysis.
 
50 
 
m
 
g of nuclear extracts from HDK1
cells was separated by 12% SDS-PAGE and transferred to a poly-
vinylidene difluoride membrane (Millipore). The immunoblot-
ting was performed with an anti–GATA-3 antibody (Santa Cruz
Biotechnology, Inc.), followed by a horseradish peroxidase–cou-
pled secondary antibody (Amersham Pharmacia Biotech), and vi-
sualized using a chemiluminescence substrate (Pierce Chemical
Co.).
 
1
 
Abbreviations used in this paper:
 
 EGFP, enhanced green fluorescent pro-
tein; HS, DNaseI-hypersensitive. 
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HS Site Mapping.
 
Cells (2 
 
3
 
 10
 
7
 
) were collected and stimu-
lated with PMA/ionomycin/cAMP for 2 h. Isolation of nuclei
and analysis of HS sites was carried out as described (41). In brief,
nuclei were suspended in 10 mM Tris, pH 7.4, 10 mM NaCl,
and 5 mM MgCl
 
2
 
 to 10
 
8
 
 nuclei per milliliter and divided into 30-
 
m
 
l
aliquots. Varying amounts of DNaseI (Worthington Biochemical)
were added to each aliquot and incubated at 37
 
8
 
C for 12.5 min.
The reaction was stopped with an equal volume of stop solution
(1% SDS, 20 mM Tris, pH 7.4, 600 mM NaCl, 10 mM EDTA,
and 50 
 
m
 
g/ml proteinase K) and incubated at 37
 
8
 
C overnight.
Genomic DNA was extracted and digested with BamHI. 4 
 
m
 
g of
each digest was separated on a 0.8% agarose gel and blotted with
the probe.
 
Results
 
GATA-3 Induces IL-4 and IL-5 in Committed as Well as
Developing Th1 Cells.
 
To explore the differential role of
GATA-3 in committed as well as developing Th1 cells, a
retroviral vector encoding GATA-3 bicistronically with
EGFP (R-GATA-3-EGFP) or control retrovirus contain-
ing EGFP only (recombinant retrovirus encoding GFP [R-
EGFP]) was introduced into Ag-specific DO11.10 TCR–
transgenic Th1 cells at different stages of development, as
well as into a committed Th1 clone as previously described
(27). Cells were then sorted on the basis of EGFP reflecting
GATA-3 expression. As previously shown, the introduc-
tion of GATA-3 into developing Th1 cells on days 1 and 2
after initiation of the cultures led to the induction of Th2-
specific cytokines and downregulation of IFN-
 
g
 
 (23, 27)
(Fig. 1). Introduction of R-GATA-3-EGFP into Th1 cells
 
after 8 d of polarization under Th1-inducing conditions
also resulted in the production of IL-4 and IL-5 upon stim-
ulation with PMA and ionomycin, and downregulation of
IFN-
 
g
 
 production, as compared with the EGFP
 
1
 
 controls
(Fig. 1) and the GFP
 
2
 
 R-GATA-3-EGFP–infected Th1
cells (GATA-3
 
2
 
; data not shown). Similar results were ob-
tained with OVA
 
323–339
 
 and APC stimulation (data not
shown). Thus, GATA-3 induced Th2-specific cytokines
and inhibited IFN-
 
g
 
 production in a Th1 population com-
posed of committed as well as developing Th1 cells. To
confirm that the effects of GATA-3 seen in 8 d polarized
Th1 cells indicated a change in committed Th1 cells, we
examined the effect of GATA-3 on Th1 cells generated by
22 d of repeated antigenic stimulation (3 wk polarized) un-
der Th1-polarizing conditions, which have previously been
shown to be committed (9). Supernatants from GATA-3
 
1
 
,
3 wk polarized Th1 cells, stimulated with PMA and iono-
mycin, contained substantial amounts of IL-4 and IL-5
(Fig. 1) and IL-10 (data not shown). In contrast, no IL-4
and IL-5 was detected in the supernatants from GFP
 
2
 
,
R-GATA-3-EGFP–infected T cells (GATA-3
 
2
 
). In addition,
a decrease in IFN-
 
g
 
 production was observed in GATA-3
 
1
 
T cells, but it was less pronounced than in 1 or 2 wk polar-
ized GATA-3
 
1
 
 
 
T cells. GATA-3 showed a similar ability to
upregulate Th2-specific cytokines in a committed Th1
clone, HDK1, but had a lesser effect on the levels of IFN-
 
g
 
production. Importantly, the phenotype of GATA-3–
expressing (GATA-3
 
1
 
)
 
 
 
HDK1 cells producing IL-4 and IL-5
was maintained over repeated Ag stimulation (data not
shown). Thus, GATA-3 can induce Th2-specific cytokines
Figure 1. GATA-3 induces IL-4 and IL-5 in developing
as well as committed Th1 cells. Naive CD4 T cells from
DO11.10 TCR–transgenic mice were stimulated with
OVA323–339 and splenic APCs under Th1-polarizing condi-
tions (IL-12 and anti–IL-4). On days 1 and 2 after stimula-
tion, T cells were infected with retroviruses encoding ei-
ther EGFP (R-EGFP) or GATA-3 bicistronically with
EGFP (R-GATA-3-EGFP), and GFP1 populations,
EGFP1 or GATA-31, respectively, were purified by flow
cytometry. A portion of noninfected T cells was restimu-
lated on day 7 with Ag and APCs under the Th1 condi-
tions and was infected on days 8 and 9 with retroviruses.
For day 22 infection, cells after 3 wk of polarization under
Th1-inducing conditions were infected with recombinant
retrovirus as above, except that the infection was repeated
for three consecutive days. On day 7 after each last stimu-
lation, GFP1 (GATA-31) or GFP2 (GATA-32) T cells
were purified by flow cytometry. A Th1 clone, HDK1,
was stimulated with KLH and splenic APCs infected with
either R-EGFP or R-GATA-3-EGFP on days 1 and 2.
GFP1 cells were purified on day 14 and stimulated with
PMA/ionomycin for 48 h, and the level of cytokines in
supernatants was determined by immunoassay. 1, 2, and 3
wk polarized Th2 cells produced z5, 15–20, or 30–50 ng/
ml, respectively. Results were representative of three ex-
periments with similar results. 
108
 
GATA-3 Induces Th2 Cytokines in Committed Th1 Cells
 
in committed Th1 cells that are unresponsive to IL-4–medi-
ated signals for this effect (9).
 
cAMP Markedly Augments GATA-3–mediated Th2 Cyto-
kine Production from Committed Th1 Cells and a Th1 Clone.
 
The effects of GATA-3 on the induction of IL-4 and IL-5,
although significant, gradually decreased as Th1 develop-
ment progressed (Fig. 1). This may reflect the loss of other
factors and/or signaling pathways in Th1 cells that might
cooperate with GATA-3 in the induction of Th2-specific
cytokines. cAMP markedly augments Th2 cytokine pro-
duction and inhibits the production of IL-2 (30, 42) and
IFN-
 
g
 
 (31). However, under no circumstances does cAMP
alone induce Th2-specific cytokines in Th1 cells (20).
Thus, we tested whether cAMP could upregulate the ef-
fects of GATA-3 on committed Th1 cells. Treatment with
cAMP markedly augmented the production of IL-4 and
IL-5 in GATA-3
 
1
 
, 3 wk polarized Th1 cells and the Th1
clone, but not in the control EGFP
 
1
 
, 3 wk polarized Th1
cells and the Th1 clone (Fig. 2 A). Consistent with its
known inhibitory effects on Th1 cytokine production (31,
42), cAMP treatment of the control EGFP
 
1
 
 Th1 clone sig-
nificantly decreased stimulation-dependent IFN-
 
g
 
 produc-
tion (Fig. 2 A), although this effect was not observed in 3
wk polarized Th1 cells. Similar results were obtained for
intracellular cytokine production in 3 wk polarized Th1
cells (data not shown) and the Th1 clone (Fig. 2 B). None
of the control EGFP
 
1
 
 HDK1 cells produced IL-4 or IL-5
in response to PMA and ionomycin stimulation. However,
7.5 and 21% of GATA-3
 
1
 
 HDK1 cells produced IL-4 and
IL-5, respectively, and their treatment with cAMP mark-
edly increased the number of IL-4– and IL-5–producing
cells (18 and 45%, respectively). Interestingly, the produc-
tion of IL-4 and IL-5 was limited to the cells expressing
 
GFP (and thus GATA-3) above a certain threshold (Fig. 2
B). Upregulation of Th2-specific cytokines by GATA-3
and cAMP was also shown at the RNA level (data not
shown).
 
Ectopic Expression of GATA-3 Induces Endogenous GATA-3
Expression in Developing but Not Committed Th1 Cells.
 
To ensure the expression of GATA-3 in cells infected with
recombinant retrovirus, we performed RNase protection
using a GATA-3–specific probe, which distinguishes the
endogenous GATA-3 transcript from the retroviral one
(Fig. 3, top and bottom bands, respectively). Endogenous
GATA-3 transcripts were easily detected in 1 wk polarized
Th2 cells (Fig. 3, lane 2) but not in Th1 cells (Fig. 3, lane
1) nor a Th1 clone, regardless of infection with control
R-EGFP (Fig. 3, lanes 5–7). On the other hand, a smaller
band, reflecting the retrovirus-derived GATA-3 transcript,
was detected in both developing Th1 cells and the Th1
clone infected with R-GATA-3-EGFP (Fig. 3, lanes 4 and
8–10). Th1 cells infected with R-GATA-3-EGFP on days
1 and 2 after primary stimulation additionally expressed en-
dogenous GATA-3 transcripts (Fig. 3, lane 4), indicating
that ectopically expressed GATA-3 induces endogenous
GATA-3 gene transcription in developing Th1 cells. In
contrast, GATA-3 did not induce another Th2-specific
transcription factor c-
 
maf
 
 (15) in developing Th1 cells at
the level of detectability in our assay (Fig. 3, lane 4). In the
committed Th1 clone, GATA-3 did not induce endoge-
nous GATA-3 gene transcription (Fig. 3, lanes 8–10), al-
though it could induce Th2 cytokine expression in the
same cells.
 
Distinct Domains of GATA-3 Are Required for IL-4 and IL-5
Expression in a Committed Th1 Clone.
 
To explore the
mechanism(s) by which GATA-3 regulates Th2-specific
Figure 2. cAMP augments GATA-3–mediated Th2 cytokine induction in commit-
ted Th1 cells and a Th1 clone as well as developing Th1 cells. GFP1 Th1 cells from
day 22 of infection and HDK1 cells infected with either R-EGFP or R-GATA-3-
EGFP as in Fig. 1 were stimulated with either PMA/ionomycin (filled bars) or PMA/
ionomycin/cAMP (open bars) for 48 h as indicated, and the level of cytokines in su-
pernatants was determined by immunoassay. (B) GFP HDK1 cells were stimulated
with either PMA/ionomycin or cAMP as indicated for 6 h, and intracellular cytokine
production was analyzed by flow cytometry as previously described (9). The data in A
and B are representative of greater than three experiments with similar results. 
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cytokine induction, we generated a series of mutant con-
structs containing either substituted amino acids or dele-
tions in one of its functional domains (Fig. 4 A). A GATA-3
mutant, dND, contains an NH
 
2
 
-terminal 140-aa deletion,
whereas KRR has a 3-aa substitution of KRR
 
®
 
AAA
between the two zinc fingers. In the human GATA-3
protein, these mutations do not perturb the ability to bind
the GATA-3 site but severely inhibit transactivation func-
tion, as determined by a reporter assay (43, 44). GATA-3
mutants dNF and dCF lack a portion of the NH
 
2
 
-terminal
and entire COOH-terminal zinc finger domains, respec-
tively. The Th1 clone was stimulated and infected with
retroviruses expressing the mutant GATA-3 proteins de-
scribed above. When analyzed by flow cytometry on day 7
after Ag and APC stimulation, 
 
z
 
80% of the cells infected
with retroviruses encoding different constructs expressed
EGFP (data not shown). Western blot analysis using an
anti–GATA-3 antibody (43) showed that mutant GATA-3
proteins of expected sizes accumulated in the nuclei of
HDK1 cells infected with retroviruses encoding the
GATA-3 constructs (Fig. 4 B, lanes 2–6) but not retrovi-
ruses containing the control EGFP (Fig. 4 B, lane 1). We
next examined the DNA binding activity of each mutant
GATA-3 protein expressed in the HDK1 cells using an oli-
gonucleotide probe from TCR-
 
a
 
 that contained the
GATA-binding sites (24). Nuclear extracts prepared from
control R-EGFP–infected cells or the Th1 clone (data not
shown) did not form any DNA–protein complex with this
probe (Fig. 4 C, lane 1). Retroviral transduction of wild-
type GATA-3 reconstituted binding to the GATA site, as
seen in 1 wk polarized Th2 cells (Fig. 4 C, lane 2). GATA-3
mutants dND and KRR retained the ability to bind the
GATA-3 site (Fig. 4 C, lanes 3 and 4). However, GATA-3
mutants lacking either a portion of the NH
 
2
 
-terminal
(dNF) or the entire COOH-terminal zinc finger domain
(dCF) failed to form a complex with the probe, despite the
high level of accumulation of the GATA-3 protein in the
nucleus (Fig. 4 C, lanes 5 and 6).
As shown earlier, HDK1 cells purified by flow cytome-
try on the basis of EGFP expression, expressing the wild-
 
type GATA-3, produced Th2 cytokines IL-4 and IL-5
(Fig. 4 D). No IL-4 and IL-5 production was induced by
the GATA-3 mutant dCF lacking the DNA-binding func-
tion. Likewise, the dND mutant lacking the major transac-
tivation domain (43) did not induce IL-4 and IL-5 produc-
tion. In contrast, substitution of three amino acids between
the two zinc fingers (KRR), which completely abolishes
transactivation of a reporter construct driven by the TCR-
 
a
 
GATA-binding sites (44), did not affect the ability to in-
duce IL-4 production. Moreover, the GATA-3 mutant
lacking a portion of the NH
 
2
 
-terminal zinc finger domain
(dNF) also retained its ability to induce IL-4, despite its in-
ability to bind to the GATA sites in the TCR-
 
a
 
 probe.
Strikingly different from its effects on IL-4 production, the
effect of GATA-3 on IL-5 production was reduced signifi-
cantly by the mutation in KRR, to below the level of de-
tection by the dNF mutation, suggesting that GATA-3
may induce IL-4 and IL-5 via distinct mechanisms. Con-
sistent results were obtained when intracellular cytokine
production was measured by flow cytometry (data not
shown).
We next examined the domains of GATA-3 required
for IFN-
 
g
 
 inhibition and IL-4 induction in developing
Th1 cells (Fig. 4 E). T cells from DO11.10 mice were
stimulated with OVA and APCs, cultured under Th1-
polarizing conditions, and infected on days 1 and 2 after stim-
ulation with retrovirus encoding either GATA-3 or the re-
spective mutants. On day 7 after primary stimulation, T
cells were stimulated with PMA and ionomycin and were
analyzed for intracellular cytokine production. T cells ex-
pressing wild-type GATA-3 were induced to produce IL-4
as shown earlier (Fig. 1), whereas, like in the case of the
Th1 clone, no IL-4 producing cells appeared in either
dND or dCF mutants, which resembled the control
EGFP-expressing cells (Fig. 4 E). Similarly, the dND and
dCF mutants abrogated the ability of GATA-3 to down-
regulate the production of IFN-
 
g
 
 (Fig. 4 E). Thus, we
concluded that the domains of GATA-3 required for IFN-
 
g
 
inhibition were closely correlated with those for IL-4 in-
duction.
Figure 3. GATA-3 induces endogenous GATA-3
but not c-maf. RNase protection assay for GATA-3 and
c-maf transcripts was performed using total cellular
RNAs as described in Materials and Methods. The lo-
cations of protected bands for c-maf and for endogenous
as well as introduced GATA-3 transcripts are indicated.110 GATA-3 Induces Th2 Cytokines in Committed Th1 Cells
GATA-3 Transactivates the IL-5 but Not the IL-4 Promoter:
c-Maf Transactivates the IL-4 but Not the IL-5 Promoter.
GATA-3 induces the production of both IL-4 and IL-5 in
Th1 cells, but it has been shown that although GATA-3
strongly transactivates the IL-5 promoter (19, 20, 22), it has
little effect on the mouse proximal IL-4 promoter (21, 22).
Cotransfection experiments with GATA-3 and reporter
constructs containing either the mouse proximal IL-5 or
IL-4 promoter, pmIL-5Luc(1.2) or pIL-4(2766)Luc, con-
firmed that GATA-3 has little effect on the IL-4 promoter
but transactivates the IL-5 promoter (Fig. 5). In contrast,
when c-maf is cotransfected with a reporter construct con-
taining the proximal IL-4 promoter, it augments the activa-
tion of this gene upon stimulation with PMA/ionomycin
as previously shown (15) (Fig. 5). However, when c-maf is
cotransfected with the proximal IL-5 promoter, it inhibits
the basal activation of this gene, which is induced with
PMA/ionomycin. Collectively, these results indicate that
the induction of IL-4 by GATA-3 requires a novel mecha-
nism(s) other than transactivation, which, however, is ob-
served for the IL-5 promoter.
GATA-3 Is Involved in Chromatin Remodeling in Commit-
ted Th1 Cells. The Th2 cytokine genes, IL-13/IL-4/
IL-5, are clustered together in a 160-Kb region of human
chromosome 5 (reference 45; syntenic mouse chromosome
11). Recently, it has been shown that development of na-
Figure 4. Construction of GATA-3 mutants and functional effects on a Th1 clone, HDK1. (A) Schematic representation of the GATA-3 mutants.
The top diagram represents wild-type GATA-3 (WT), beginning from aa 1–443 (25). The NH2- and COOH-terminal zinc fingers are indicated by
hatched boxes. GATA-3 mutants are designated by the domain deleted or amino acids substituted. (B) HDK1 cells were stimulated and infected as de-
scribed in Fig. 2, with retroviruses encoding wild-type or the indicated GATA-3 mutants (A). Nuclear extracts of HDK1 cells were prepared and ana-
lyzed for expression of GATA-3 proteins by Western blot using a GATA-3 mAb (43). (C) Nuclear extracts of HDK1 cells from B were analyzed for
DNA binding activity to the oligonucleotide probe from the TCR-a containing GATA-binding sites as previously described (20). Different band posi-
tions reflect changes in the size and the conformation of the mutated GATA-3 proteins. (D) Distinct domains of GATA-3 are required for IL-4 and IL-5 ex-
pression in a Th1 clone. GFP1 cells infected with retroviruses encoding wild-type or the indicated GATA-3 mutants were purified by flow cytometry
and stimulated with PMA/ionomycin/cAMP for 48 h. The levels of cytokines in the supernatants were determined by immunoassay. (E) Domains of
GATA-3 required for IFN-g inhibition and induction of IL-4 in developing Th1 cells. T cells from DO11.10 mice were stimulated under Th1 condi-
tions and infected with retroviruses encoding either wild-type or mutant GATA-3 on day 1 and 2 as described in Fig. 1. T cells were stimulated with
PMA/ionomycin on day 7, and intracellular cytokine production was analyzed as previously described (9). Data represent the events from GFP1 gated
populations, in greater than three experiments.111 Lee et al.
ive Th cells into Th2 cells is associated with increased
chromatin accessibility of the IL-4 and IL-13 loci. Five HS
sites were detected within a BamHI fragment spanning the
IL-4 gene in a Th2 clone D10 (46), and three HS sites
were detected within the intergenic region between the
IL-13 and IL-4 genes (41). Thus, we examined the possi-
bility that GATA-3 may affect chromatin accessibility of
the IL-4 locus when expressed in the Th1 clone. Four HS
sites are shown in the Th2 clone, D10 (Fig. 6). HS site IV,
which has been shown to be present both in Th1 and Th2
cells, appeared both in control R-EGFP– and R-GATA-3-
EGFP–infected HDK1 cells. However, the HS site II,
which maps to the second intron of the IL-4 gene, is Th2
specific and not observed in the Th1 clone, even when in-
fected with the control R-EGFP. In contrast, HS site II was
induced in the Th1 clone, when infected with R-GATA-
3-EGFP (Fig. 6), suggesting that GATA-3 is involved in
chromatin remodeling of the IL-4 locus, which selectively
occurs during Th2 development.
Discussion
The development of an appropriate subset of Th cells is
critical for determining the outcome of an immune re-
sponse to various pathogens. Strongly polarized Th1/Th2
responses are manifested in chronic diseases such as autoim-
mune and allergic disorders and persistent infections (2–5).
Thus, a means of altering stable Th phenotypes has im-
mense importance for developing therapeutic strategies.
Thus far, there has been no indication that stable Th1 and
Th2 cells can be changed, by any external signals or by
transcription factors, to produce cytokines of the opposite
phenotype.
Here, we demonstrate that GATA-3 converted commit-
ted Th1 cells and a Th1 clone to express Th2 cytokines,
and cAMP synergistically augmented this GATA-3 effect.
Thus, our results suggest that differential distribution of
GATA-3 in Th1 and Th2 cells may be one of the main
molecular events accounting for the irreversibility of the
Th phenotypes, which has been explained earlier by the se-
lective loss of cytokine signaling between Th subtypes (11,
12, 14). Consistent with this hypothesis, our recent study
Figure 5. GATA-3 and c-maf differentially regu-
late mouse IL-4 and IL-5 promoter activities. EL-4
cells were cotransfected with 1 mg of reporter con-
struct, pIL-4(2766)Luc (13) or pmIL5Luc(1.2) (42)
and the transactivators in the expression vector, ei-
ther pMEGATA3 (25) (0, 1, and 2 mg) or pMEc-
maf (0, 1, and 2 mg), by DEAE dextran procedure
as described previously (20). Transfection efficiency
was monitored using 0.1 mg of pRSV-LacZ.
pMEc-maf encoding full-length murine c-maf (40)
was cloned by PCR. After 36-h incubation, cells
were either unstimulated (open bars) or stimulated
(filled bars) for 12 h with PMA (10 ng/ml)/iono-
mycin (1 mM), and luciferase activity was measured
in whole cell extracts and normalized to protein
mass as described (65). The data is representative of
more than three independent experiments.
Figure 6. GATA-3 induces chromatin remodeling of the IL-4 locus in
a Th1 clone, HDK1. Nuclei from PMA/ionomycin/cAMP-stimulated
cells were treated with 0 mg/ml (lanes 1, 4, and 7), 9 mg/ml (lanes 2, 5,
and 8), and 12 mg/ml (lanes 3, 6, and 9) of DNaseI and probed with a
HindIII–PstI fragment (2797 to 2306) of the IL-4 gene (41). Arrow-
heads indicate positions of BamHI cleavage sites. Locations of the HS sites
and a probe are indicated by arrows and a thick bar, respectively.112 GATA-3 Induces Th2 Cytokines in Committed Th1 Cells
indicates that the activation of Stat6:ER, a conditionally ac-
tive form of Stat6, which mimics the IL-4–mediated signal-
ing without ligation of IL-4 and its receptor, did not in-
duce GATA-3 or Th2 cytokines in committed Th1 cells
but did so in developing Th1 cells (39).
Alternative systems have generated different results re-
garding GATA-3 effects on Th1 and Th2 cytokine expres-
sion. CD4 1 T cells from GATA-3–transgenic mice express
Th2 cytokines when cultured under Th1-polarizing condi-
tions without an apparent effect on IFN-g expression (16).
However, retroviral transduction of GATA-3 into devel-
oping Th1 cells not only induced Th2 cytokines but also
impaired Th1 development by inhibiting IL-12Rb2 and
IFN-g expression (23, 27). Importantly, it is likely that in-
hibition of IFN-g versus upregulation of IL-4 production
may be closely correlated, as we now show that mutations
in the GATA-3 C-finger (dCF) and transactivation do-
mains (dND) abrogated both effects (Fig. 4 E). However, it
was suggested that GATA-3 effects were limited to an early
developmental window during Th1 development (23). In-
deed, the ability of GATA-3 to inhibit IFN-g production
becomes less effective but not absent as Th1 cells become
committed (Fig. 1). Although the reduction in the effect
on IFN-g production over time might be due predomi-
nantly to an effect on IL-12Rb expression, an additional
direct effect on IFN-g expression cannot be ruled out. In
addition, the possibility that the differences between the
clone and the bulk populations could be attributed to a
particular characteristic of that clone has to be reexamined
in future in a greater number of clones.
In contrast to earlier studies, however, we now show
that IL-4 and IL-5 can still be induced by GATA-3 in
committed Th1 cells and a Th1 clone (Fig. 1). This dis-
crepancy between our results and those of Ouyang et al.
(23) may result from higher levels of GATA-3 expression
being attained in our system. Indeed, intracellular cyto-
kine staining using the unsorted Th1 clone infected with
R-GATA-3-EGFP showed that IL-4 and IL-5 production
was limited to the cells expressing EGFP above a certain
threshold level (Fig. 2 B). Thus, the level of GATA-3 may
determine its ability to induce Th2-specific cytokines.
Dose-dependent lineage determination has also been ob-
served with other GATA factors in hematopoietic develop-
ment (47, 48).
Our results revealed that cAMP markedly augmented
the effect of GATA-3 on Th2 cytokine induction in a Th1
clone and in polarized Th1 cells, albeit to a lesser extent
(Fig. 2). However, cAMP on its own did not induce Th2
cytokine production in polarized Th1 cells or the Th1
clone (data not shown). Molecules elevating intracellular
cAMP levels have been reported to inhibit cytokine pro-
duction by Th1 clones, while cAMP augments cytokine
production by Th2 clones (31, 32, 42). Furthermore,
cAMP levels have been shown to be higher in Th2 than
Th1 cells (30). However, the mechanism for the synergism
between cAMP and GATA-3 is not clear. It is possible that
cAMP may induce or activate other Th2 transcription fac-
tors that are involved in the transcription of Th2 cytokine
genes, including JunB and NFIL-6 (49–52), through the
activation of protein kinase A (42). cAMP may induce
phosphorylation of GATA-3 and/or other proteins coop-
erating with GATA-3. Alternatively, cAMP may modify
certain signals and/or transcription factors in Th1 cells to
reconstitute signals that normally occur in Th2 cells (32,
53–56). In addition, it has recently been shown that cAMP
leads to phosphorylation of GATA-3 via p38 (Ray, A.,
personal communication. Interestingly, GATA-3 com-
pletely reversed cAMP-mediated IFN-g inhibition, raising
the possibility that the opposite effects of cAMP on cyto-
kine production by Th1 and Th2 cells may be due, at least
in part, to the presence or absence of GATA-3 in these two
cell types (Fig. 2 A).
Our results highlight the importance of the NH2-termi-
nal transactivation as well as the COOH-terminal zinc fin-
ger domains of GATA-3 for both IL-4 and IL-5 induction.
Perhaps surprising is our finding that the NH2-terminal
zinc finger domain of GATA-3, although critical for DNA
binding, was dispensable for IL-4 induction. The NH2-ter-
minal zinc finger domain of GATA-3 was critical for the
production of IL-5, a gene for which functional GATA
sites have been characterized in the promoter (19, 20). Dif-
ferent susceptibilities to GATA-3 mutations between IL-4
and IL-5 induction were also observed with KRR, a 3-aa
substitution between the zinc fingers, suggesting that
GATA-3 may adopt different mechanisms for the induc-
tion of these genes. This idea is further supported by previ-
ous studies on the IL-4 and IL-5 promoters (19–22). We as
well as others have shown the involvement of GATA-3 in
the activation of the IL-5 promoter through binding to a
critical DNA element, IL-5C, in conjunction with other
inducible factors (18–20). In contrast, the role of GATA-3
on the IL-4 promoter is not clear. Recent data clearly
showed that GATA-3 activated the transcription of IL-5,
but not the IL-4 promoter in a B lymphoma line M12 (22)
and the thymoma line EL-4 (Fig. 5), in spite of the pres-
ence of putative GATA sites in the IL-4 promoter (19, 21).
In this study, we support these findings and show that in
contrast to GATA-3, c-Maf augments transactivation of the
IL-4 promoter as previously shown (15) but does not trans-
activate the IL-5 promoter (Fig. 5). These results suggest
that GATA-3 controls IL-4 expression by a mechanism
other than transactivation.
Recent studies indicate that the development of naive
Th cells into Th1 and Th2 subsets resulted in chromatin
remodeling of cytokine gene loci (41, 46). However, the
molecular mechanism for initiating or maintaining Th1-
and Th2-specific chromatin remodeling was not clear. Our
results indicate that GATA-3 can induce Th2 cytokines in
committed Th1 cells in which chromatin accessibility of
the IL-4 and IL-13 loci is limited and that this effect is ac-
companied by chromatin remodeling of these loci (Fig. 6)
identical to that shown for IL-4–driven Th2 cells (46) and
more recently in GATA-3–transduced Th2 cells from Stat6
knockout mice (57). We demonstrate that GATA-3 is crit-
ical for Th2-specific commitment by showing that it in-
duces this same HS sites in committed Th1 cells as that ob-113 Lee et al.
served in IL-4–driven Th2 cells. Putative GATA sites have
also been identified in the regions around which the Th2-
specific HS sites are mapped (41, 46). The role of GATA-1
in chromatin remodeling of the b-globin locus has been
well established (58). Moreover, a recent report indicates
that GATA factors interact via their COOH-terminal zinc
finger with the transcriptional coactivator CREB binding
protein, which has a histone acetyltransferase activity (59).
Our result demonstrating the essential role of the COOH-
terminal zinc finger of GATA-3 for Th2 cytokine induc-
tion further supports the hypothesis for the role of GATA
factors in chromatin remodeling.
The molecular basis for Th2-specific expression of
GATA-3 is largely unknown. There is an indication that
this may involve upregulation by IL-4 via Stat6 as well as
downregulation by IL-12 via Stat4 (23). We recently found
that activation of Stat6 induced GATA-3 and c-maf expres-
sion in developing Th1 cells even in the complete absence
of IL-4, suggesting that GATA-3 and c-Maf may be down-
stream targets of the Stat6 signaling pathway (39). Although
we did not apparently detect the induction of c-maf by
GATA-3, this may be due to the possibility that c-maf lev-
els are below the detectability of our assay. Alternatively,
the stage after stimulation of the Th cells when we exam-
ined c-maf expression may not be optimal for detection of
this transcription factor, as it has been suggested that c-maf
may be upregulated by TCR ligation (15), and we mea-
sured mRNA expression 7 d after Ag-specific stimulation.
Our results provide evidence that ectopically expressed
GATA-3 induced endogenous GATA-3, suggesting that
an autoregulatory mechanism could play a role in Th2 dif-
ferentiation, as recently suggested by Ouyang et al. (57).
However, endogenous GATA-3 induction by ectopically
expressed GATA-3 was limited to developing Th1 cells
and did not occur in a Th1 clone. This result may provide
an insight into the mechanism by which Th2 cells maintain
GATA-3 expression and thus the production of Th2 cy-
tokines, whereas Th1 cells do not. It is possible that other
factors or pathways lacking in Th1 cells may be additionally
required for GATA-3 induction and/or that active inhibi-
tory mechanisms may be operating in Th1 cells to suppress
GATA-3 expression. In this respect, it is worthwhile to
note a recent report describing a silencer element in the
human GATA-3 promoter that confers T cell–specific ac-
tivity of the promoter (60). Thus, Th2-specific expression
of GATA-3 may be under the control of multiple regula-
tory mechanisms involving extracellular signals and intra-
cellular factors.
In conclusion, our study demonstrates that ectopic ex-
pression of GATA-3 in combination with cAMP can con-
vert committed Th1 cells to produce Th2-specific cyto-
kines. The ability of GATA-3 to induce the Th2-specific
cytokines IL-4 and IL-10 and thus change a committed
Th1 phenotype upon antigenic stimulation has important
implications for the treatment of autoimmune pathologies,
which are often mediated by Th1 cells (61, 62). The pro-
duction of Th2-specific cytokines in these Th1 cells in-
duced by GATA-3 could also serve to negatively regulate a
generalized Th1 response. IL-10 and IL-4 are known to in-
hibit the production of IL-12 and IL-18 (5, 63) by mac-
rophages and dendritic cells, and these factors are required
for the maintenance of a Th1 phenotype (64). Thus, the
production of IL-4 and IL-10 in Th1 cells, in response to
Ag-specific stimulation in the context of ectopic GATA-3,
could break the loop maintaining autoimmune Th1-medi-
ated pathologies. The ability to alter a committed Th1 phe-
notype by retroviral transduction of GATA-3 to produce
Th2-specific cytokines may therefore provide a potential
for therapeutic intervention in certain Th1-related diseases.
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